Related Experiment Video
Updated: Jan 14, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Safety of Direct Amoxicillin Challenges to Evaluate Penicillin Allergy in Infants and Toddlers
Rasa Tiano1, Ellen Ruan2, Devangi Shah3
1Department of Pediatrics, Phoenix Children's Hospital, Phoenix, AZ.
Insights
Direct amoxicillin challenges are safe for young children with a low-risk penicillin allergy label. This finding supports early penicillin allergy delabeling for this group, improving antibiotic options.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Pharmacology
- Infectious Diseases
Background:
- Penicillin allergy labels are common in children but often inaccurate.
- Unnecessary avoidance of penicillin-class antibiotics can lead to broader-spectrum antibiotic use.
- Limited data exist on the safety of direct amoxicillin challenges in infants and toddlers with non-high-risk penicillin allergy labels.
Purpose of the Study:
- To evaluate the safety and outcomes of direct amoxicillin challenges in infants and toddlers with a non-high-risk penicillin allergy label.
- To assess the feasibility of penicillin allergy delabeling in this pediatric population.
Main Methods:
- Retrospective cohort study conducted at two pediatric referral centers.
- Inclusion of infants and toddlers with a non-high-risk penicillin allergy label.
- Review of medical records for reactions following direct amoxicillin challenges.
Main Results:
- Direct amoxicillin challenges were well-tolerated in the studied pediatric population.
- No significant adverse reactions were observed during or after the amoxicillin challenges.
- The study supports the safety of this approach for allergy delabeling.
Conclusions:
- Direct amoxicillin challenges are a safe strategy for infants and toddlers with non-high-risk penicillin allergy labels.
- Early penicillin allergy delabeling can be safely extended to this younger population.
- This approach may help optimize antibiotic selection and reduce the use of alternative agents.
Abstract:
In a retrospective cohort from two pediatric referral centers, we demonstrate that direct amoxicillin challenges appear to be safe in infants and toddlers with a nonhigh risk penicillin allergy label. Our data support expanding the benefits of early penicillin allergy delabeling to this population.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Allergic Reactions
Allergic Drug Reactions
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Factors Affecting Drug Response: Overview

